Project Gullstrand - European Project for the Determination of Average Biometric Values of Human Eyes
NCT ID: NCT01173614
Last Updated: 2016-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1646 participants
OBSERVATIONAL
2011-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy in Decreasing Myopia Progression of the Proposed Ophthalmic Lens Prototypes
NCT05250206
Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People
NCT07297810
Clinical Investigation for a Multifunction Ophthalmic Measurement Device
NCT06565091
Accuracy of Corneal Astigmatism in Different Region Modes
NCT03299530
Myopia Prevention With Reading Glasses
NCT05030103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal subjects
Subjects with two normal eyes.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ametropia between -10D and +10D.
Exclusion Criteria
* Prior ocular surgery
* Amblyopia, refraction larger than ±10D
* Corneal or retinal pathologies
* Systemic diseases (e.g. diabetes, multiple sclerosis, …)
* More than 5 months pregnant at the moment of testing
* Recent wear of hard contact lenses
* Epilepsy (if C-Quant is used).
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Vision Institute Clinical Research Network
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jos Rozema, MSc PhD
Role: STUDY_CHAIR
Dept of Ophthalmology, Antwerp University Hospital. Edegem, Belgium
Marie-José Tassignon, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Dept of Ophthalmology, Antwerp University Hospital. Edegem, Belgium
Sotiris Plainis, MSc PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Vision and Optics (IVO), University of Crete, School of Health Sciences, Heraklion Crete, Greece 71003
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VISSUM - Instituto Oftalmológico de Alicante
Alicante, Spain, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zocher MT, Rozema JJ, Oertel N, Dawczynski J, Wiedemann P, Rauscher FG; EVICR.net. Biometry and visual function of a healthy cohort in Leipzig, Germany. BMC Ophthalmol. 2016 Jun 7;16:79. doi: 10.1186/s12886-016-0232-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECR-CCRS-2010-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.